1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Med P:n som i programpaket. Om datatortyr och signifikansfiskeri
(
- Contribution to journal › Article
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
(
- Contribution to journal › Scientific review
- 2000
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
- 1998
-
Mark
Nytt behandlingsprogram vid avancerad ovarialcancer. Tillfredsställande resultat med decentraliserad cytostatikaterapi
(
- Contribution to journal › Article
- 1997
-
Mark
Bättre prognos vid epitelial ovarialcancer
(
- Contribution to journal › Article
- 1996
-
Mark
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
(
- Contribution to journal › Article
-
Mark
Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group
(
- Contribution to journal › Article
- 1994
-
Mark
Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases
(
- Contribution to journal › Article